We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$69.4B
AUM Growth
-$5.97B
Cap. Flow
-$8.1B
Cap. Flow %
-11.68%
Top 10 Hldgs %
11.91%
Holding
4,468
New
542
Increased
1,601
Reduced
1,691
Closed
599

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.03B
2
UNH icon
UnitedHealth
UNH
+$686M
3
TSLA icon
Tesla
TSLA
+$387M
4
ABT icon
Abbott
ABT
+$380M
5
CVX icon
Chevron
CVX
+$328M

Sector Composition

Rank Sector Weight
1 Technology 20.26%
2 Healthcare 16.96%
3 Consumer Discretionary 12.82%
4 Consumer Staples 9.14%
5 Industrials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGC icon
2726
Vanguard Morningstar Mega Cap ETF
MGC
$9.99B
$657K ﹤0.01%
+4,200
New +$621K
GUSH icon
2727
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$255M
$656K ﹤0.01%
+21,600
New +$630K
DARE icon
2728
Dare Bioscience
DARE
$18.3M
$654K ﹤0.01%
59,902
+12,480
+26% +$148K
GAN
2729
DELISTED
GAN Ltd
GAN
$654K ﹤0.01%
399,017
+29,443
+8% +$41.9K
NGM
2730
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$654K ﹤0.01%
252,600
-76,900
-23% -$274K
ACCS
2731
ACCESS Newswire
ACCS
$25.6M
$653K ﹤0.01%
34,738
+955
+3% +$18.6K
ORTX
2732
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$652K ﹤0.01%
125,218
+34,100
+37% +$174K
PALL icon
2733
abrdn Physical Palladium Shares ETF
PALL
$618M
$649K ﹤0.01%
28,500
IDEV icon
2734
iShares Core MSCI International Developed Markets ETF
IDEV
$31.7B
$648K ﹤0.01%
+10,600
New +$650K
PYXS icon
2735
Pyxis Oncology
PYXS
$168M
$648K ﹤0.01%
253,229
+159,029
+169% +$504K
RMNI icon
2736
Rimini Street
RMNI
$449M
$646K ﹤0.01%
134,930
-45,700
-25% -$189K
ABSI icon
2737
Absci
ABSI
$1.32B
$644K ﹤0.01%
423,375
+166,475
+65% +$268K
MYPS icon
2738
PLAYSTUDIOS Inc
MYPS
$77.9M
$643K ﹤0.01%
130,900
+21,300
+19% +$93.3K
CAL icon
2739
Caleres
CAL
$431M
$637K ﹤0.01%
26,600
-280,864
-91% -$6.29M
LENZ
2740
LENZ Therapeutics
LENZ
$166M
$635K ﹤0.01%
34,871
+2,271
+7% +$45.4K
AVO icon
2741
Mission Produce
AVO
$1.11B
$633K ﹤0.01%
52,200
-4,200
-7% -$49.5K
TDCX
2742
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$632K ﹤0.01%
79,918
+28,100
+54% +$232K
IWO icon
2743
iShares Russell 2000 Growth ETF
IWO
$14.3B
$631K ﹤0.01%
+2,600
New +$596K
KE
2744
Kimball Electronics
KE
$595M
$631K ﹤0.01%
22,825
-21,850
-49% -$517K
SCHV
2745
Schwab US Large-Cap Value ETF
SCHV
$15.7B
$631K ﹤0.01%
+28,200
New +$616K
XPRO icon
2746
Expro Ltd
XPRO
$1.79B
$630K ﹤0.01%
35,527
-172,201
-83% -$3.11M
LX
2747
LexinFintech Holdings
LX
$241M
$627K ﹤0.01%
273,897
-122,309
-31% -$297K
OPBK icon
2748
OP Bancorp
OPBK
$232M
$624K ﹤0.01%
74,000
-37,042
-33% -$314K
MGV icon
2749
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
$623K ﹤0.01%
6,000
+4,000
+200% +$407K
LGF.B
2750
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$621K ﹤0.01%
74,339
+21,900
+42% +$216K

Similar funds

Renaissance Technologies's Q2 2023 Portfolio in Review

As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.

  • Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
  • Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
  • Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
  • Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
  • Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
  • Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.